Burkhart Erin, GVP and Chief Accounting Officer at BioMarin Pharmaceutical Inc. ($BMRN), sold shares on the open market twice in the last 365 days for a total of nearly $200,000. Her most recent sale occurred on May 20, 2025. These sales rank 8,439th among 11,678 individual insiders in our database, where the average is $8.6 million across about 6.4 transactions. Erin made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 10, 2026 | GILEAD SCIENCES, INC. | $GILD | Burkhart Erin | SVP, Controllership | A | Restricted Stock Unit | 2355 | $0.00 | 11,245.0000 | 1,256,000,000 | 26.49% | 0.00% |
| March 10, 2026 | GILEAD SCIENCES, INC. | $GILD | Burkhart Erin | SVP, Controllership | A | Non-qualified Stock Option (Right to Buy) | 5455 | $0.00 | 5,455.0000 | 1,256,000,000 | 9999.99% | 0.00% |
| Sept. 22, 2025 | GILEAD SCIENCES, INC. | $GILD | Burkhart Erin | SVP, Controllership | A | Restricted Stock Unit | 8890 | $0.00 | 8,890.0000 | 1,255,000,000 | 9999.99% | 0.00% |
| May 19, 2025 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Burkhart Erin | GVP, Chief Accounting Officer | F | Common Stock | 996 | $59.27 | 15,959.0000 | 196,708,000 | 5.87% | 0.00% |
| May 20, 2025 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Burkhart Erin | GVP, Chief Accounting Officer | S | Common Stock | 1786 | $59.31 | 14,173.0000 | 196,708,000 | 11.19% | 0.00% |
| March 19, 2025 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Burkhart Erin | GVP, Chief Accounting Officer | S | Common Stock | 1295 | $71.52 | 16,955.0000 | 196,708,000 | 7.10% | 0.00% |
| March 17, 2025 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Burkhart Erin | GVP, Chief Accounting Officer | A | Stock Option (Right to Buy Common Stock) | 9230 | $0.00 | 9,230.0000 | 196,708,000 | 9999.99% | 0.00% |
| March 17, 2025 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Burkhart Erin | GVP, Chief Accounting Officer | A | Common Stock | 5970 | $0.00 | 18,252.0000 | 196,708,000 | 48.61% | 0.00% |
| March 14, 2025 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Burkhart Erin | GVP, Chief Accounting Officer | F | Common Stock | 823 | $69.44 | 12,282.0000 | 196,708,000 | 6.28% | 0.00% |
| Feb. 24, 2025 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Burkhart Erin | GVP, Chief Accounting Officer | S | Common Stock | 1344 | $68.38 | 13,105.0000 | 196,708,000 | 9.30% | 0.00% |
| Aug. 13, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Burkhart Erin | GVP, Chief Accounting Officer | S | Common Stock | 714 | $90.00 | 14,449.0000 | 191,595,000 | 4.71% | 0.00% |
| May 17, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Burkhart Erin | GVP, Chief Accounting Officer | F | Common Stock | 993 | $76.97 | 15,163.0000 | 191,595,000 | 6.15% | 0.00% |
| April 10, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Burkhart Erin | GVP, Chief Accounting Officer | S | Common Stock | 2286 | $90.00 | 16,156.0000 | 191,595,000 | 12.40% | 0.00% |
| March 15, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Burkhart Erin | GVP, Chief Accounting Officer | A | Stock Option (Right to Buy Common Stock) | 7050 | $0.00 | 7,050.0000 | 191,595,000 | 9999.99% | 0.00% |
| March 18, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Burkhart Erin | GVP, Chief Accounting Officer | F | Common Stock | 372 | $83.87 | 18,442.0000 | 191,595,000 | 1.98% | 0.00% |
| March 15, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Burkhart Erin | GVP, Chief Accounting Officer | A | Common Stock | 4720 | $0.00 | 18,814.0000 | 191,595,000 | 33.49% | 0.00% |
| May 16, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Burkhart Erin | GVP, Chief Accounting Officer | F | Common Stock | 796 | $92.02 | 14,094.0000 | 188,963,000 | 5.35% | 0.00% |
| March 15, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Burkhart Erin | GVP, Chief Accounting Officer | A | Common Stock | 3760 | $0.00 | 14,890.0000 | 188,963,000 | 33.78% | 0.00% |
| March 15, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Burkhart Erin | GVP, Chief Accounting Officer | A | Stock Option (Right to buy Common Stock) | 5720 | $0.00 | 5,720.0000 | 188,963,000 | 9999.99% | 0.00% |